Safety, Efficacy, and Pharmacokinetics of Adalimumab in Japanese Children With Juvenile Rheumatoid Arthritis

NCT00690573 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Juvenile Rheumatoid Arthritis

Interventions

BIOLOGICAL: Adalimumab

Sponsor

Abbott

Collaborators

[object Object]